Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Sugar-coated nanoparticles could target triple-negative breast cancer
Triple-negative breast cancer is particularly aggressive and difficult to treat, but recent research may offer…
First genetically engineered cancer model in naked mole rats developed
Researchers have created the first genetically engineered model of lung cancer in naked mole rats,…
Vagus nerve modulation key to combating cancer-associated cachexia
The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing cancer-associated cachexia (CAC),…
The OJC Episode 44: Melanoma Update with Georgina Long
The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 44 in our series The…
FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer
- The Lancet Public Health: Banning tobacco sales among young people could prevent 1.2 million lung cancer deaths, global modelling study suggests
- Faster, more sensitive lung cancer detection from a blood draw
- New addition to standard-of-care treatments for non-small-cell lung cancer patients has potential to increase progression-free survival
Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
- ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer
- ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line IO in advanced bladder cancer
- Study pinpoints potential protein biomarkers of bladder cancer
A big heart: Olivia Newton-John remembered by Professor Jonathan Cebon
Over more than 20 years, Professor Jonathan Cebon, former Medical Director of Cancer Services at the Olivia Newton-John Cancer Wellness…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.